March 11, 2014

Prasco Laboratories announced on Tuesday that it has started shipping the generic version of Hectorol (doxercalciferol) 0.5-, 1.0- and 2.5-mcg capsules, each in 50-count bottles under the Prasco label.

October 17, 2013

Prasco Labs will distribute an authorized generic for reducing serum phosphate in patients with end-stage renal disease under a contract with Shire, Prasco said Thursday.

August 8, 2013

Keryx Biopharmaceuticals announced the submission of a new drug application to the Food and Drug Administration seeking approval for the marketing and sale of Zerenex (ferric citrate coordination complex), the company's drug candidate for the treatment of elevated serum phosphorus levels, or hyperphosphatemia, in patients with chronic kidney disease on dialysis.

July 16, 2013

Diplomat Specialty Pharmacy is supporting a summer camp for children with chronic kidney disease, the company said Tuesday.

July 31, 2012

CVS Caremark’s MinuteClinic has teamed up with the American Heart Association in a nationwide effort to improve the identification, treatment and management of high blood pressure.

June 7, 2012

The Food and Drug Administration has approved a drug for kidney disease made by Perrigo.

March 28, 2012

The Food and Drug Administration has approved a new treatment for anemia in patients with chronic kidney disease.

February 25, 2011

Advances in kidney care have not led to successful efforts to improve therapy for patients with Type 1 diabetes, according to a study published in the Journal of the American Society of Nephrology.

December 1, 2010

Drug maker Keryx Biopharmaceuticals got promising results from a late-stage clinical trial of a drug for treating elevated phosphate levels, also known as hyperphosphatemia, in patients on kidney dialysis, the company said Tuesday.

September 22, 2010

Drug makers Abbott and Reata Pharmaceuticals have signed an agreement concerning a drug for chronic...

February 1, 2010

Tiny areas of brain damage caused by injury to small blood vessels can signal an...